review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Rosario Pivonello | Q57068197 |
Gaetano Lombardi | Q64495535 | ||
Annamaria Colao | Q64495559 | ||
P2093 | author name string | Leo J Hofland | |
Diego Ferone | |||
Steven W J Lamberts | |||
P921 | main subject | physiology | Q521 |
P304 | page(s) | S13-21 | |
P577 | publication date | 2007-04-01 | |
P1433 | published in | European Journal of Endocrinology | Q3060778 |
P1476 | title | Novel insights in dopamine receptor physiology | |
P478 | volume | 156 Suppl 1 |
Q41444993 | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus |
Q35653457 | Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence |
Q49949879 | Access to the CNS: Biomarker Strategies for Dopaminergic Treatments. |
Q41022357 | Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound Tissues |
Q57493008 | Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
Q38603636 | Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond |
Q54353594 | Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins. |
Q30409324 | Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease |
Q24657821 | Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers |
Q42366040 | Catecholamine Metabolism in a Shetland Pony with Suspected Pheochromocytoma and Pituitary Pars Intermedia Dysfunction |
Q49898385 | Comparison of the effects of the L-dopa and insulin tolerance tests on cortisol secretion. |
Q34582707 | Discovery of GPCR ligands for probing signal transduction pathways |
Q45924308 | Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis. |
Q33869687 | Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells |
Q43530496 | Dopamine D1 receptors mediate dopamine-induced duodenal epithelial ion transport in rats |
Q24620977 | Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2 |
Q21198880 | Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance |
Q42178524 | Dopamine D2 Receptor Is Involved in Alleviation of Type II Collagen-Induced Arthritis in Mice |
Q88548916 | Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland |
Q48793052 | Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity. |
Q34038390 | Dopamine receptors in human adipocytes: expression and functions |
Q46498179 | Effects of an attachment-based intervention on daily cortisol moderated by dopamine receptor D4: a randomized control trial on 1- to 3-year-olds screened for externalizing behavior |
Q38743093 | Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study |
Q38151882 | Efficacy of medical treatment in Cushing's disease: a systematic review. |
Q48311863 | Evidence for the involvement of dopamine in stress-induced suppression of reproduction in the cichlid fish Oreochromis mossambicus. |
Q37314246 | Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acrome |
Q58780116 | Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D receptor activation using multi-biomarker pharmacokinetic/pharmacodynamic modelling |
Q47615136 | From frog integument to human skin: dermatological perspectives from frog skin biology |
Q24652245 | Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms |
Q24273361 | Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs |
Q38165863 | Molecular basis of pharmacological therapy in Cushing's disease |
Q90970792 | New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion |
Q34970259 | PharmGKB summary: dopamine receptor D2 |
Q37895053 | Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands |
Q37853323 | Resistant prolactinomas |
Q22252576 | Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis |
Q34490765 | SKF83959, an agonist of phosphatidylinositol-linked D(1)-like receptors, promotes ERK1/2 activation and cell migration in cultured rat astrocytes |
Q37222365 | Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome |
Q90183440 | Source of dopamine in gastric juice and luminal dopamine-induced duodenal bicarbonate secretion via apical dopamine receptor 2 |
Q27010590 | The Treatment of Cushing's Disease |
Q37357146 | The dopamine D1 receptor is expressed and facilitates relaxation in airway smooth muscle |
Q52615455 | The dopamine D1 receptor is expressed and induces CREB phosphorylation and MUC5AC expression in human airway epithelium. |
Q38614574 | The neurobiological basis of human aggression: A review on genetic and epigenetic mechanisms |
Q37857296 | Therapy of aggressive pituitary tumors |
Search more.